Updated and revised, this edition offers evidence?based guidance for treating pediatric infections with expert commentary on selecting and dosing antimicrobial agents. Detailed information on antifungal therapies, prophylactic protocols and systemic drugs ensures precise treatment decisions.

Completely updated and revised, the 32nd edition of this best-selling reference delivers the latest evidence-based recommendations for the treatment of infectious diseases in children. Each disease is accompanied by expert commentary, helping clinicians choose the best antimicrobial options based on current research and clinical experience. It includes detailed descriptions of all antimicrobial agents available today, with complete dosing regimens.

New in the 32nd Edition

This edition is fully reviewed for updates, and references are updated throughout the book. Highlights of updated or new guidelines include

• Chapter 5, "Preferred Therapy for Specific Fungal Pathogens": update to candidiasis therapy for systemic infections
• Chapter 6, "Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins": dosage updates for posaconazole and isavuconazole
• Chapter 15, "Antimicrobial Prophylaxis/Prevention of Symptomatic Infection": updates to
  • Table A, "Postexposure Antimicrobial Prophylaxis to Prevent Infection": tuberculosis, neonatal herpes simplex virus
  • Table C, "Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection": new information for recurrent mucocutaneous herpes simplex virus
  • Table D, "Surgical Procedure Prophylaxis": intraoperative Re-Dosing interval (h) for prolonged surgery updated throughout; piperacillin/tazobactam therapy added for complicated appendicitis or other ruptured colorectal viscus
• Chapter 18, Table A, "Systemic Antimicrobials With Dosage Forms and Usual Dosages": now includes
  • Ceftobiprole medocaril sodium, Zevtera
  • Geptotidacin, Blujepa
  • Minocycline ER, Emrosi
  • Paromomycin, Humatin